Related eBooks

Frontiers in Clinical Drug Research - Anti-Allergy Agents is an exciting eBook series comprising a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The first volume of this series sheds light on new therapies that can be employed for allergic reactions in patients (both traditional and non-traditional therapies), nutrition based therapies and the use of substances such as omalizumab and adrenaline to counter inflammatory response and anaphylaxis in patients. </p><p> Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field.

Frontiers in Clinical Drug Research - Anti-Allergy Agents is an exciting eBook series comprising a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The second volume of this series brings 7 reviews which cover neuro- and immunomodulating therapies for asthma and COPD, antioxidant therapies for allergies, allergic rhinitis medications and more. Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field.

Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The third volume of this series brings 5 reviews which cover the following topics: H1 receptor selectivity, chronic spontaneous urticaria therapy, smooth muscle cell Ca2+ signaling pathway targeting for asthma therapy, allergic rhinitis and endosomal toll-like receptors. Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field.

Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The fourth volume of this series brings 5 reviews which cover the following topics: Anti-inflammatory and Immunomodulatory properties of medicinal plant products Helminth therapy: a new tool for treatment of allergic diseases An overview of anti-allergic medications in paediatric population In-silico approaches in drug discovery and design of anti-allergic agents Microbiota and allergy: possible Interventions Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field.

Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The fifth volume of this series brings 5 reviews which cover the following topics: - Resistin: an irresistible therapeutic target for inflammatory diseases, allergy-related disorders, and cancer - Asthma in adults: evaluation, prevalence, and its clinical management - Nitrogen-containing heterocycles as anti-allergy agents - Experimental and clinical studies on the effects of nigella sativa and its constituents on allergic and immunological disorders - Aspirin desensitization/challenge in patients with cardiovascular diseases: current trends and advances Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field.

This handbook covers Optical Coherence Tomography Angiography (OCT-A) with a specific focus on choroidal and vitreoretinal disorders. It serves as an invaluable resource for teaching and aiding daily clinical decision-making in the field. Book chapters dissect the fundamentals of angiography through OCT, offering guidance on OCT-A and insights into macular perfusional findings across various vitreoretinal and choroidal pathologies. From diabetic retinopathy to autoimmune diseases and neovascularization, the book addresses prevalent vascular entities encountered in routine practice. Furthermore, it explores innovative approaches, including antivascular endothelial growth factor molecules and extended-release delivery devices, contributing significantly to the diagnostic and decision-making processes in clinical and surgical retina care. Each chapter is contributed by experts in the relevant subspecialty. Key Features: Practical, patient-centered guide emphasizing a clinical approach. Demonstrative clinical cases for enhanced understanding. Evaluation of perfusional indices using noninvasive and noncontact imaging techniques. High histopathological correlation of structural tissue characterization with microvascular evaluation. Exploration of new perfusion concepts and their role in disease pathogenesis. Part 2 covers advanced topics in OCT-A for choroidal and vitreoretinal disorders. Chapters explore macular perfusional repercussions in obstructive venous vascular phenomena, OCT-A findings in retinal infarction, and the role of macular perfusion in myopic macular traction maculopathy. Further discussions include postoperative perfusional findings in vitreoretinopathy, distinctions in choroidal vasculopathies, and the application of OCT-A in managing pathological choroidal neovascularization. The part concludes with a review of postoperative membrane formation, the usefulness of OCT-A in neurodegenerative diseases, and the evaluation of arterial occlusions and choroidal neovascularization management.

Cardiovascular mortality in women is more frequent than breast cancer mortality, a fact which is often overlooked. Women's Heart and Estrogens explores this important women’s health issue with respect to estrogen levels (before and after menopause) as the hormone has been known to mediate cardiovascular effects in women. The handbook includes a description of the structure and biological activity of estrogen and follows up with a detailed reference on the genetics behind estrogen and its effect on the cardiovascular system. Subsequent chapters cover the effects of estrogens on the stages of atherogenesis, actions of estrogens on the on the vascular wall and on cardiovascular metabolic pathways, causes leading to the development of early onset of coronary heart disease in young women (such as vasculitis and autoimmune diseases)[Obaid ur Rahman1] , hypercoagulable states, myocardial infarction in hallucinogenic drug abusers, non-atherosclerotic and atherosclerotic coronary heart disease, hormone replacement therapy and postmenopausal risk factors. Medical professionals will also find handy guidelines for cardiovascular disease prevention in women. Women's Heart and Estrogens offers knowledge to readers in a clear and simple manner with detailed images and summaries in each chapter. Guidelines are also presented in a chronological context which demonstrates the development of cardiovascular disease prevention and risk management strategies for women over the years.

Advancements in Cancer Research: Exploring Diagnostics and Therapeutic Breakthroughs is a comprehensive resource that highlights the latest innovations in cancer research. This book bridges the gap between cutting-edge science and clinical applications, offering insights into the molecular mechanisms, diagnostic advancements, and novel therapeutic strategies revolutionizing cancer care. Organized into thematic sections, the book explores critical areas such as molecular biomarkers, immunotherapy, nanotechnology in diagnostics and treatment, and targeted therapies. Topics include the role of TP53 mutations in colorectal cancer, nanocarriers for melanoma therapy, RNA-based therapeutics for colon cancer, and biomaterials for bone tumor management. Readers will also discover how emerging technologies like nanotheranostics and transethosomes are paving the way for personalized cancer care. Key Features: - Insights into molecular and nanotechnology-driven cancer therapies. - Exploration of diagnostics and biomarker applications. - Multidisciplinary approaches to advancing patient care. - Analysis of current trends and prospects in oncology.

Infections and Male Infertility (Part I): General Pathophysiology, Diagnosis, and Treatment explores the complex link between infections and male infertility, providing a comprehensive examination of their impact on reproductive health. This book integrates key concepts from molecular biology, immunology, and clinical practice to highlight the pathophysiology, diagnosis, and treatment of infection-induced infertility. Key Features: - Multidisciplinary insights from molecular biology, immunology, and reproductive medicine. - Comprehensive coverage of infections affecting male fertility, including diagnosis and treatment. - Discussion of emerging therapies, including stem cell research and personalized medicine.

Nanomaterials in Glioblastoma Research, Diagnosis, and Therapy offers a comprehensive exploration of how nanotechnology is revolutionizing the fight against glioblastoma (GBM), one of the deadliest and most treatment-resistant brain cancers. The book covers the molecular and epigenetic mechanisms underlying GBM, laying the foundation for innovative strategies in diagnosis and therapy. It highlights cutting-edge advances, including nanomaterial-based biosensors for early diagnosis, biomaterials to enhance immunotherapy, and novel therapeutic approaches like gold nanoparticles, cold plasma, and combinational nanomedicine. The book also addresses critical challenges such as overcoming the blood-brain barrier through oral delivery nanostructures and provides future perspectives on clinical applications. Key Features: - Insights into GBM genetics, epigenetics, and molecular pathways. - Applications of nanomaterials in drug delivery, imaging, and immunotherapy. - Detailed coverage of advanced diagnostics and therapeutic strategies. - Future directions and challenges in nanotechnology-based GBM treatment.